会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • Novel adenoviral vector and methods for making and using the same
    • 新型腺病毒载体及其制备和使用方法
    • US20040106193A1
    • 2004-06-03
    • US09930832
    • 2001-08-15
    • Mark A. KayHiroyuki Mizuguchi
    • C12P021/06A61K039/12A61K039/23A61K039/235C12N015/00C12N015/09C12N015/63C12N015/70C12N015/74
    • C12N15/86A61K48/00C07K14/8125C12N2710/10343C12N2800/80
    • In vitro methods for making a recombinant adenoviral genome, as well as kits for practicing the same and the recombinant adenovirus vectors produced thereby, are provided. In the subject methods, the subject genomes are prepared from first and second vectors. The first vector includes an adenoviral genome having an E region deletion and three different, non-adenoviral restriction endonuclease sites located in the E region. The second vector is a shuttle vector and includes an insertion nucleic acid flanked by two of the three different non-adenoviral vectors present in the first vector. Cleavage products are prepared from the first and second vectors using the appropriate restriction endonucleases. The resultant cleavage products are then ligated to produce the subject recombinant adenovirus genome. The subject adenoviral genomes find use in a variety of application, including as vectors for use in a variety of applications, including gene therapy.
    • 提供了制备重组腺病毒基因组的体外方法,以及用于实施其的试剂盒和由此产生的重组腺病毒载体。 在本发明方法中,从第一和第二载体制备受试者基因组。 第一载体包括具有E区缺失的腺病毒基因组和位于E区中的三个不同的非腺病毒限制性内切核酸酶位点。 第二载体是穿梭载体,并且包含侧翼于第一载体中存在的三种不同非腺病毒载体中的两个的插入核酸。 使用适当的限制性内切核酸酶从第一和第二载体制备裂解产物。 然后将所得裂解产物连接以产生本发明的重组腺病毒基因组。 主题腺病毒基因组可用于各种应用,包括用于各种应用的载体,包括基因治疗。